Furthermore, western blot analysis demonstrated that metastatic markers, MMP-9 and MMP-2 were significantly affected in primary pancreatic tumors and other metastatic organs (lung, liver, and spleen). This evidence concerns the gene MMP2 and pancreatic neoplasm.